Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Total Debt: 2022-2023

Historic Total Debt for Gossamer Bio (GOSS) over the last 2 years, with Dec 2023 value amounting to $12.4 million.

  • Gossamer Bio's Total Debt fell 53.97% to $9.6 million in Q1 2024 from the same period last year, while for Mar 2024 it was $9.6 million, marking a year-over-year decrease of 53.97%. This contributed to the annual value of $12.4 million for FY2023, which is 47.35% down from last year.
  • Gossamer Bio's Total Debt amounted to $12.4 million in FY2023, which was down 47.35% from $23.6 million recorded in FY2022.
  • Gossamer Bio's 5-year Total Debt high stood at $23.6 million for FY2022, and its period low was $12.4 million during FY2023.
  • Moreover, its 2-year median value for Total Debt was $18.0 million (2022), whereas its average is $18.0 million.
  • Data for Gossamer Bio's Total Debt shows a maximum YoY tumbled of 47.35% (in 2023) over the last 5 years.
  • Over the past 2 years, Gossamer Bio's Total Debt (Yearly) stood at $23.6 million in 2022, then slumped by 47.35% to $12.4 million in 2023.